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deviation. Within each BH, the set-up remained stable within 1.0 mm. 
EPID images showed that σintra was 1.4 mm in both u- and v-directions, 
increasing the σtotal by about 0.5 mm (depending on the value of σinter). 
σinter was 1.2 and 1.7 mm with online CBCT protocol, but recalculated 
to be 2.3 and 2.7 mm in case of set-up on laser marks only. Without 
protocol, Σu would have been 3.3 mm and Σv 2.7 mm; with an online 
CBCT protocol this reduced to 1.2 (u) and 1.4 (v) mm. Because many 
patients changed their BH pattern during or after the first week of 
treatment, both the offline NAL and weekly eNAL protocols were less 
effective, indicating that more intensive imaging protocols have to be 
applied. CTV-PTV margins can be reduced from 10 mm (no protocol) 
to 7 mm with a weekly eNAL protocol, 5 mm with a daily eNAL 
protocol, or 4 mm with an online protocol.  
Conclusions: For accurate radiotherapy breast treatments using a 
voluntary DIBH technique a daily imaging protocol is required. 
Although CBCT provides full information about patient positioning and 
is needed for a 3D treatment beam setup, imaging of the medio-
lateral beam can be a fair alternative for treatments with tangential 
beams only, resulting in a decrease of patient dose. 
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Purpose/Objective: To explore the potential of scanned helium ion 
beams compared to scanned proton beam therapy in a treatment 
planning study. The physical characteristics of helium ions (different 
peak to plateau ratio and sharper beam penumbra) seem to make it a 
promising candidate for radiation oncology. 
Materials and Methods: All treatment plans were created with the 
treatment planning system Hyperion, utilizing a novel pencil beam 
algorithm for both proton and helium ion beams. Employing the same 
conceptual dose calculation algorithm for both ions enables a precise 
comparison without having to account for deviations within 
algorithms. Sample treatment plans were calculated for prostate 
cases and skull base tumours. For both scenarios two laterally opposed 
beams were applied. Treatment plan optimisation was done with the 
same algorithm, constraints and scanning pattern for a given 
treatment site for both particle species.  
Prostate patients received 78 Gy to the PTV, defined as the CTV with 
an isotropic 5mm margin. For the prostate plans two organs at risk 
(rectum and bladder) were delineated. 
The skull base patients were prescribed 54 Gy to the PTV, delineated 
using the CTV plus a 3mm isotropic margin. For the skull base plans 
five organs at risk (eyes, optic nerves and brainstem) were delineated. 
Results were evaluated using dose volume histograms (DVH) and 
target coverage and conformity. 
Results: Two prostate patients have been evaluated so far (PTV 
volumes ~126 ccm). Dmedian for both patients was 78.7 ± 0.4 Gy. D2% for 
prostate patient 1 was 80.1 vs 79.8 Gy with a V95% of 98.6 vs 99.2 % for 
protons and helium ions, respectively. Corresponding values for 
patient 2 were similar (D2% of 80.5 vs 79.8 Gy with a V95% of 98.7 vs 
99.2 % for protons or helium ions). The conformity index for patient 1 
was 0.06 vs 0.04 for protons and helium ions, for patient 2 0.07 vs 
0.04. 
For the skull base patient 1 (average PTV 81.7 ccm) PTV Dmedian was 
54.3 ± 0.1 Gy for both particles. D2% was 56.2 vs 55.6 Gy with a V95% of 
96.1 vs 98.6 % for protons and helium ions, respectively. 
Corresponding values for patient 2, having a smaller PTV (volume of 
30.9 cm), were: D2% 55.8 vs 55.4 Gy with a V95% of 97.6 vs 99.3 % for 
protons or helium ions. The conformity index for skull base patient 1 
was 0.11 vs 0.07, for patient 2 0.09 vs 0.05 for protons and helium 
ions.  
Organ at risk doses for both patients did not exceed the tolerance 
values as specified in the QUANTEC report. 
Conclusions: Systematically steeper PTV DVH curves were obtained 
for helium ions, with a reduced D2% and increasing V95%. The dosimetric 
improvements of treatment plan parameters when using helium ions 
compared to protons motivate a more thorough investigation of 
helium ions. Current work in progress deals with improvements in RBE 
modelling of helium ions during optimisation to fine tune the model.  
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Purpose/Objective: Internal target and organ motion during 
treatment is a challenge in radiotherapy (RT) of the prostate and the 
involved elective targets, with residual motion being present also 
following image-guidance strategies. The aim of this study was to 
investigate organ motion induced dose degradations for the prostate, 
seminal vesicle and the pelvic lymph node targets when treating these 
targets with proton therapy, using different image-guidance and 
delivery strategies. 
Materials and Methods: Four patients were selected from a larger 
series as they displayed large inter-fractional variation in bladder and 
rectum volume. Intensity-modulated proton therapy (IMPT) plans were 
generated using both simultaneous integrated (SIB) and sequential 
boost delivery. For each technique, three isotropic margin expansions 
(in the range of 4-10mm) were evaluated for the clinical target 
volume of prostate (CTV-p), seminal vesicles (CTV-sv) and lymph 
nodes (CTV-ln). Simulation of the dose degradations for all treatment 
plans were based on dose re-calculations for the 8-9 repeat CTs 
available for each patient, after applying rigid registrations to 
reproduce set-up based on either intra-prostatic fiducials or bony 
anatomy. 
Results: The simulated dose received by 99% of the target volume 
(D99) and generalized equivalent dose (gEUD) showed substantial 
inter-patient variations. For 40% of the investigated scenarios, the 
patient average simulated D99 for all targets were within 2GyE from 
the planned. The largest difference between simulated and planned 
dose was seen for the CTV-sv when using SIB delivery, with an average 
relative reduction in D99 of 13% and 15% for the largest margin 
expansion, when positioned using fiducials and bony anatomy 
respectively (Table 1). 
 
  
Conclusions: The most severe dose degradations were found for the 
seminal vesicles, but they were also evident for the lymph node 
target. The degradations could not be completely resolved, neither by 
using the largest margin expansion nor with the choice of set-up. With 
fiducial set-up the prostate target was robust against the inter-
fraction changes. 
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Purpose/Objective: To evaluate the correlation between the 
reference DWH of bladder wall (DWH) outlined by using MRI images 
and DVH of bladder including filling, dose surface (DSH) and DVH of 
artificial bladder wall in prostate cancer patients planned both with 
3D-conformal and IMRT techniques. 
Materials and Methods: 27 prostate cancer patients were submitted 
to CT and MRI scans that were used to draw bladder walls. External 
bladder surfaces were then used to create artificial bladder walls 
applying automatic contractions of 5 (DVH5), 7 (DVH7) and 10 mm 
(DVH10). For each patient a 3DCRT (box technique) and an IMRT (5 
fields) treatment plan was generated prescribing at ICRU reference 
point 77.4 Gy (1.8 Gy/fr) to PTVprostate and 61.2 Gy (1.8 Gy/fr) to 
PTVprostate+seminal vesicle Gy(1.8Gy/fr). For all the patients the 
mean difference and standard deviation between the DWH and the 
other surrogates, both in percentage (%) and absolute volume(cm3), 
was calculated and considered for the analysis. Correlation was 
quantified for selected dose-volume/surface parameters by R 
Spearman correlation coefficient. 
Results: %DWH was found to be correlated to DVH5, DVH7 and DVH10 
(maximum average deviations below 2%, SD<5%) with DVH5 that 
showed the best agreement. Slightly better correlation was found for 
absolute (R=0.80-0.94) compared to relative (R = 0.66-0.92) 
histograms. DSH was also foundto be highly correlated to DWH 
(maximum difference<2% and 9% for 3DCRT andIMRT, respectively, 
and R>0.64), although slightly higher deviations were generally found. 
DVH was not a good surrogate of DWH (R<0.7 for most ofparameters). 
When comparing the two treatment techniques, Spearman’s 
correlation coefficients were significantly lower for IMRT compared to 
3DCRT both in relative (p=0.002) and absolute (p=0.0007) values. 
Conclusions: DVH of the bladder including filling wasn’t a good 
surrogate of DWH. DSH resulted to be correlated to DWH as well as 
DVH5,7,10 with slightly better results for absolute compared to 
relative histograms. As far as treatment planning techniques, 
Spearman’s correlation coefficients for IMRT planning resulted 
significantly lower compared to 3DCRT.  
These results suggest to use DVH of the bladder wall obtained by 
performing automatic 3D contractions of external surface of the 
bladder inclinical practice.  
The study is supported by a grant from Associazione Italiana Ricerca 
sul Cancro (AIRC-IG13090) 
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Purpose/Objective: The large amount of images taken during image 
guided/adaptive treatments, increases the possibility to assess the 
early response of tissues to the treatment. The possibility of early 
(i.e. during the first weeks of treatment) measuring image-based 
parameters that may potentially predict the outcome of the 
treatment in terms of both tumour response and toxicity is of 
particular interest. 
Regarding head-and-neck cancer (HNC), parotid glands (PGs) are 
known to experience large deformation and this may be related to 
acute toxicity (i.e. xerostomia). The aim of this study is to found 
image based score parameters that could be useful to early predict 
final PG variations. 
Materials and Methods: 92 PGs (46 patients) from two Institutions 
(group A and B) were analyzed based on CT images acquired during 
IMRT treatment. Patients were treated with radiotherapy (+ 
concomitant chemotherapy) to 58.1/70 Gy in 35 fractions (median 
values, dose of tumor and nodes PTVs), 29 with SIB approach. For all 
patients, diagnostic kVCT images were acquired at the begin of the 
treatment and at the end and additional kVCTs were acquired during 
the treatment, weekly in group A, one at mid-treatment in group B. 
Image registration was performed between initial CT and the others, 
using an in home developed non-rigid approach based on free-form 
deformation (FFD) and B-splines. PG contours, drawn by experts on 
the initial CT, were automatically propagated to the other images 
using a previously validated algorithm. 
PG deformations were described by the rates of density variation (rΔρ 
[HU/day]), volume variation (rΔvol [mm3/day]) in different parts of 
treatment. Student t-test, multi-variate logistic (MVA) including ROC 
curve analysis and assessment of predictive value of the models based 
on area under the curve (AUC) evaluations were performed. 
Results: As shown in Figure 1, PG density and volume rates are larger 
during the first weeks of treatment, especially for density rate 
variation r?ρ where it results to be highly significant (group A: -0.495 
vs -0.046, p-value=0.0001). When considering the risk of experiencing 
a large density or volume change at the end of therapy (defined as a 
value larger of the quartile of the population), logistic regression 
indicates that they can be predicted by the changes in the first two 
weeks with a moderately high predictive value (AUC > 80%). Similar 
results with a lower predictive value (AUC around 70%) were found 
when looking to the mid-term changes of A+B groups. 
 
  
Conclusions: The rate of PG volume and density variations is larger at 
the begin of the treatment; this effect is more pronounced for density 
changes. Based on the early variations, it is possible to predict with a 
good approximation the final PG changes. This result may be used to 
early identify patients which may be subject to larger variations and 
then possibly selected for adaptive re-planning. 
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Purpose/Objective: The development of the Utrecht design, hybrid 
1.5T MRI linear accelerator offers the ability to perform online MRI-
guided adaptive radiotherapy (ART). This MRI guided ART allows for 
the creation of an optimal treatment plan on the actual anatomy for 
every single treatment fraction. Hereby margins can be reduced due 
to the absence of inter fraction motion and set-up errors. 
Additionally, MRI's superior soft-tissue contrast allows direct tumor 
visualization instead of indirect features used on a CT. These features 
open the possibility for dose escalation. Yet this daily optimization 
requires a fast automated contour propagation and treatment 
planning to be feasible in clinical practice. We propose and evaluate 
an automated workflow for online MRI guided ART for rectal cancer 
boost therapy. 
Materials and Methods: Until now, 10 rectal cancer patients (T2-3 N0-
1 M0-1) underwent pre-treatment and 3-4 consecutive daily fraction 
T2 MR scans. Pre-treatment target volumes and OAR were delineated 
by an experienced radiation oncologist. These contours were then 
propagated to the 3 or 4 consecutive daily fraction MRI's by 
deformable image registration (DIR) of the pre-treatment MRI to the 
fraction MRI. This automated propagation was performed via a multi 
step approach (consecutive Euler, affine and B-spline transforms) 
using the Elastix toolkit (Klein 2010). PTV margins between 1 - 8 mm 
in plane and 4 - 8 mm out of imaging plane, were then applied to the 
transformed CTV and GTV. For each margin, a 7 beam IMRT boost 
treatment plans was made. A dose of 50 Gy was prescribed to the 
PTVCTV and a total dose of 60 Gy was prescribed to the PTVGTV. For 
planning, a fast Monte Carlo based IMRT planning system was used 
(Bol 2012). The dosimetric evaluation of the treatment plans was done 
on golden standard contours. These are obtained by manual correction 
and approval by radiation oncologist of the propagated contours. D99% 
of the gold standard CTV and GTV were evaluated. When a D99% 
